Entries by stopdirfees

, ,

Take a Stand Against DIR Fees

Published by AmerisourceBergen: “Direct and indirect remuneration (DIR) fees are wreaking havoc on balance sheets across community pharmacies, with many asking what can be done right now. It is reasonable to expect that pharmacy reimbursements are fair, accurate and timely, yet DIR fees are misleading, confusing and retroactive. This lack of transparency, as well as […]

, ,

New Legislation Aims to Prohibit DIR Fees

Published by Drug Topics: “Retail pharmacists are optimistic that Medicare direct and indirect remuneration (DIR) fees could end, if new bills proposed in the U.S. Senate and House are passed. In mid-February, Senators Shelley Moore Capito (R-WV) and Jon Tester (D-MT) introduced legislation, Senate Bill 413, which would prohibit pharmacy DIR fees from being applied […]

,

DIR Fees: Strain on Specialty Pharmacies, Patients and More

Published by Avella: “There has been a great deal of conversation in the healthcare industry recently surrounding direct and indirect remuneration, or “DIR” fees. These fees are charged to pharmacies by Pharmacy Benefit Managers (PBMs), and are causing a dramatic and negative impact to specialty pharmacies and the patients they serve. This white paper details: […]

,

Pharmacists Survey: Prescription Drug Costs Skewed by Fees on Pharmacies, Patients

Published by The National Community Pharmacists Association: “ALEXANDRIA, Va. (June 28, 2016) Most independent community pharmacists consistently encounter misleading and confusing fees imposed by prescription drug middlemen that negatively impact both pharmacies and patients and distort medication costs and reimbursement rates, according to a recent survey of 640 pharmacists conducted by the National Community Pharmacists […]

,

Contact Your Elected Officials

Published by The National Community Pharmacists Association: “Urge your legislators to co-sponsor newly introduced legislation in both the U.S. Senate and the House of Representatives that would curb abusive DIR fees. H.R.1038 sponsored by Representatives Morgan Griffith (R-Va.) and Peter Welch (D-Vt.)would explicitly prohibit PBMs in Medicare Part D from retroactively reducing payments to pharmacies […]